NASDAQ:LVGO

Livongo Health (LVGO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$139.77
$139.77
50-Day Range
$136.67
$148.08
52-Week Range
$18.76
$151.05
Volume
N/A
Average Volume
3.04 million shs
Market Capitalization
$14.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LVGO stock logo

About Livongo Health Stock (NASDAQ:LVGO)

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

LVGO Stock News Headlines

They say it’s ‘unstoppable’ – How I made 43,509%
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
See More Headlines
Receive LVGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Livongo Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/28/2020
Today
4/27/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer Programming, Data Processing, & Other Computer Related
Sub-Industry
N/A
Current Symbol
NASDAQ:LVGO
CIK
N/A
Fax
N/A
Employees
471
Year Founded
N/A

Profitability

Net Income
$-55,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$170.20 million
Book Value
$5.37 per share

Miscellaneous

Free Float
N/A
Market Cap
$14.20 billion
Optionable
Not Optionable
Beta
1.81
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

LVGO Stock Analysis - Frequently Asked Questions

How were Livongo Health's earnings last quarter?

Livongo Health, Inc. (NASDAQ:LVGO) released its quarterly earnings data on Wednesday, October, 28th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.05 by $0.11. The company earned $106.10 million during the quarter, compared to the consensus estimate of $95.57 million. Livongo Health had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 12.20%.

What other stocks do shareholders of Livongo Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), DocuSign (DOCU), Tesla (TSLA), Block (SQ), PayPal (PYPL), Salesforce (CRM), Zoom Video Communications (ZM), CrowdStrike (CRWD) and Fastly (FSLY).

When did Livongo Health IPO?

Livongo Health (LVGO) raised $230 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 10,700,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

This page (NASDAQ:LVGO) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners